New resources published September 2025

11 Sep 2025

We are pleased to announce that the following new resources from HQIP-commissioned audits and programmes have been published. Focused on maternity and perinatal care, hip fracture, and cancer (seven reports), they include data, findings, infographics, recommendations and more, to support quality improvement:

Maternity and perinatal care

Hip fracture

Cancer

  • Primary breast cancer2025 report National Audit of Primary Breast Cancer (NAoPri/NATCAN) Based on care received by people diagnosed with primary breast cancer from 2020 to 2022 in England and Wales, this report found that, among those diagnosed with primary breast cancer (Stage 0 to 3C), three-year all-cause survival was 92%, while three-year breast cancer-specific survival was 97%.
  • Metastatic breast cancer 2025 report National Audit of Metastatic Breast Cancer (NAoMe/NATCAN) Based on care received by people diagnosed with metastatic breast cancer from 2020 to 2022 in England and Wales, this report found that the percentage of patients who survived for at least one year was 65%, and for three years was 44% (England and Wales combined, where metastatic disease was identified at the time of initial diagnosis).
  • Ovarian cancer 2025 report National Ovarian Cancer Audit (NOCA/NATCAN) This report is based on care received by women diagnosed with ovarian cancer between 1 January and 31 December 2022 in England, and 1 January 2022 and 31 December 2023 in Wales. It found that approximately seven out of ten patients in England, and three out of four in Wales, survived at least one year after diagnosis.
  • Pancreatic cancer 2025 report National Pancreatic Cancer Audit (NPaCA/NATCAN) This report is based on care received by people diagnosed with pancreatic cancer between 1 January 2021 to 31 December 2022 in England, and 1 January 2022 and 31 December 2023 in Wales. It found that the percentage of people who survived for 30 days was 78% (England) and 79% (Wales).
  • Non-Hodgkin lymphoma 2025 report National Non-Hodgkin Lymphoma Audit (NNHLA/NATCAN) This report found that the percentage of people who survived at one year was 81% (England) and 83% (Wales), and at two years was 74% in England (data not available for Wales).
  • Kidney cancer 2025 report National Kidney Cancer Audit (NKCA/NATCAN) This report is based on care received by people diagnosed with kidney cancer from 2018-2022 in England, and from 2022-2023 in Wales. It describes national trends in kidney cancer diagnoses and treatments, and contains five recommendations for improvement.
  • Oesophago-gastric cancer 2025 report National Oesophago-Gastric Cancer Audit (NOGCA/NATCAN) Based on care received by people diagnosed with oesophago-gastric between 1 January 2022 and 31 December 2023 in England and Wales. This report highlights both the strengths and the ongoing challenges facing oesophago-gastric cancer services in England and Wales.

All reports: All HQIP-commissioned reports can be accessed via our dedicated reports webpage. Stay up to date: Join our mailing list to receive notifications when new reports are published.